Sidefarma

Sidefarma is a Portuguese pharmaceutical company specialized in the development, manufacture, and commercialization of prescription and non-prescription medicines, medical devices, food supplements, and cosmetics. Operating as a Contract Manufacturing Organization (CMO), the company produces solid, semi-solid, and liquid dosage forms, specializing in small to medium-sized batches for regulated markets. Sidefarma's own product portfolio includes well-known brands such as Dolocalma (metamizole), Lidonostrum (lidocaine), and Systral. Founded in 1977 and headquartered in Lisbon, Portugal, the company was acquired by private equity firm Atena Equity Partners in 2021 to expand its production capacity and international footprint.